Clinical Trial Update: A Study of Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating three treatment combinations with zidovudine, lamivudine, and indinavir in HIV infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Indinavir (indinavir)
• Lamivudine (lamivudine)
• Zidovudine (Zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED